A Phase 3 APOLLOE4 study is underway to evaluate the effects of the experimental drug ALZ-801 on the elderly with early-onset Alzheimer's disease and two copies of APOE4, referred to as the APOE4/4 genotype (Hey et al., 2018). The gene discussed is APOE; the disease is Alzheimer disease.